Compare XPEL & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XPEL | AORT |
|---|---|---|
| Founded | 1999 | 1984 |
| Country | United States | United States |
| Employees | 1337 | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2019 | 1996 |
| Metric | XPEL | AORT |
|---|---|---|
| Price | $45.16 | $23.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $56.00 | $49.40 |
| AVG Volume (30 Days) | 150.7K | ★ 546.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.12 | ★ 165.62 |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $476,200,000.00 | $298,836,000.00 |
| Revenue This Year | $12.64 | $14.20 |
| Revenue Next Year | $11.98 | $11.20 |
| P/E Ratio | $44.94 | ★ N/A |
| Revenue Growth | 13.27 | ★ 18.01 |
| 52 Week Low | $31.50 | $19.16 |
| 52 Week High | $55.91 | $48.25 |
| Indicator | XPEL | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 42.09 | N/A |
| Support Level | $45.60 | N/A |
| Resistance Level | $46.71 | N/A |
| Average True Range (ATR) | 1.35 | 0.00 |
| MACD | -0.39 | 0.00 |
| Stochastic Oscillator | 23.02 | 0.00 |
XPEL Inc is a supplier of protective films, coatings, and related services principally to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from Product, which includes Paint protection film and Window film. The company derives revenue from Service, which includes Software, Cutbank credits, and Installation labor. The majority of revenue is derived from the United States.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.